A
All funds
out of scope
Analyst signals
Portfolio activity and matriculation
Metrics use all recorded activity through 21 Jul 2026 across series a. Later-round outcomes are capped at the period end.
100%companies with a later round · 1/1
1000000.00×median round-size step-up · n=1
Not availablemedian valuation step-up · n=0
0%recorded-solo rate · 0 solo / 2 syndicated
Healthcare · 1 companies
These are activity signals, not fund-return metrics. Round capital is the full disclosed financing amount, not this fund's check size. “Recorded solo” means only one investor is present in the source data and is a lead signal, not verified lead status; syndicated rounds are a co-investor or follower signal. IRR, TVPI, DPI, ownership, exits, and market beta cannot be calculated from the available records.
People
Team
A
D
D
J
J
K
L
L
R
R
S
Sterling Snead
Advisor
Portfolio
Investments
Full financing histories for portfolio companies. Highlighted rounds are those where windham-venture-partners is recorded as an investor.
Nebula Genomics
Healthcare
Nebula Genomics is a personal genomics company that provides advanced DNA testing through 30x Whole Genome Sequencing, decoding 100% of a user's DNA. Founded by Harvard and MIT Professor George Church, the company analyzes saliva samples to offer insights into health, ancestry, and genetic traits. Nebula Genomics prioritizes user privacy and control over their data, while also offering opportunities to participate in scientific research. Their services, which are intended for research, informational, and educational use, are also available through DNA Complete.